Pharmaceutical R-Pharm, one of Russia’s leading drugmakers, has won a tender in Russia for the supply of Viekira Pak (ombitasvir, paritaprevir, ritonarvir tablets, dasabuvir tablets), a drug for the treatment of hepatitis C for state needs this year, according to recent statements of the company and senior officials of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 17 May 2018